β-Cyclodextrin with Sodium Alginate based Nanosponges Preparation and Characterization in the Removal of Organic Toxin: p-Cresol in the Simulated Biological Fluids

Author:

Abdul Azeez Syed1,Sultana Afreen1,Hajera Amtul1

Affiliation:

1. Department of Pharmaceutics, Deccan School of Pharmacy, Affiliated to Osmania University, Dar-Us-Salam, Aghapura, Hyderabad - 500001, Telangana-India.

Abstract

Sodium alginate (SA)-based β-cyclodextrin(β-CD) can show an amazing adsorption capacity and are considered as secure and biocompatible frameworks for evacuating harmful particles from the body. Tyrosine, an amino acid which is found in certain nourishment and food constituents is changed over into p-Cresyl sulfate by intestine microbiota and on the off chance that this cannot be evacuated from the body, it will come-up as a dangerous uremic toxin in the body and rapid removal of this toxic molecule is relevant especially for patients affected by chronic kidney disease. Based on the necessity in the removal of this protein bound uremic toxin, Innovative cyclodextrin polymers were synthesized with different concentrations of sodium alginate to form nanosponges which are able to remove p-Cresol (Phenolic molecule), before it converted into the toxic form i,e,. p-Cresyl sulfate in the body. Furthermore, in vitro studies were carried out using optimal concentrations of sodium alginate with β-cyclodextrin-NS formulations by assessing physicochemical properties, stability, phenol adsorption capacity and in vitro toxicity. Nanosponges (NSs) were found to be of 1:2 proportion of β-cyclodextrin with sodium alginate respectively as NS2-formulation with an adsorption efficiency of in-vitro phenol toxin is 72%. In contrast, this subsidiary was more-steady in gastrointestinal media. In conclusion, this idea proposes that CD-NS details are secure and successful in expelling harmful atoms from the body. Their potential utilization in veterinary or human medication may diminish dialysis recurrence and lead to decreased phenol arrangement which concurrently decreases the cardiovascular and renal burden.

Publisher

A and V Publications

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Ion-Sensitive in situ gelling Solution containing Tobramycin for Management of Ocular Infections;Research Journal of Pharmacy and Technology;2023-09-30

2. Comparative Characterization of Marketed Antacid Granules;Asian Journal of Research in Pharmaceutical Sciences;2023-08-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3